BioCurex, Inc.
OTC BB: BOCX
www.biocurex.com
BioCurex is a leading edge biotechnology company with proprietary and patented technologies in the area of cancer diagnostics. The Company has developed a blood test that detects 90% of all cancers based on the cancer marker, RECAF™. The RECAF test has a high sensitivity and specificity for breast and lung cancers, which are two of the most common and deadly cancers where there are no accurate cancer markers available today. BioCurex data also indicates that the RECAF test detects early stages of breast and prostate cancers when therapies can be much more effective.

BioCurex diagnostic platform has been independently validated with licenses and data presentations with Abbott Laboratories (ABT-NYSE) at an international cancer congress. BioCurex also has licensed its RECAF technology to Abbott Laboratories and Inverness Medical Innovations, Inc. (IMA-AMEX) for commercialization in certain areas.

ICON LEGEND  Yahoo Finance Data & News  Company Profile (PDF)  Company Web Site

Taglich Brothers Initiates Coverage on BioCurex, Inc. BioCurex, Inc. (OTC.BB:BOCX - News), based in Richmond, British Columbia, Canada, is a development stage company. BioCurex has developed a broad-spectrum cancer blood test that could potentially detect several major cancers with greater accuracy than existing tests for widely used tumor markers. The company's blood test is based on a new proprietary cancer marker named RECAF, which is found on most cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells. (full story) Strategic American Oil Corporation Provides Update on the Waterflood North and Koliba Operations CORPUS CHRISTI, Texas, Aug. 3, 2010 (GLOBE NEWSWIRE) -- Strategic American Oil Corporation (OTCBB:SGCA - News) (the "Company") completed primary leasing for its Waterflood North prospect in the Illinois Basin and has received an initial independent engineering report on the first of three target zones by Stewart Producers, Inc. of Mt. Vernon, Ill. This preliminary independent engineering report shows the potential for economic oil production and will allow Strategic American Oil to move the project to the next stage of development expeditiously. (full story) BioCurex Cancer Monitoring Data Accepted for Presentation at International Cancer Marker Meeting RICHMOND, British Columbia, July 29, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX - News) today announced that the International Society of Oncology and Biomarkers Congress Scientific Committee has accepted BioCurex's presentation on the RECAF blood test potential to monitor cancer recurrence and treatment. The meeting will be held Sept. 3-8, 2010 in Munich, Germany and is broadly attended by scientists, physicians and biotechnology companies involved in cancer diagnostics. (full story) More Articles

There are no events to display at this time. Complete Events List

Greyson International Inc.
GYSN.PK
www.jennifergreyson.com
Greyson International, Inc., which commenced business in October 1997, develops skin care, hair care, and bath and body products and have to date developed its initial line of products, called Aspirations by Jennifer Greyson. The Aspirations by Jennifer Greyson product line uses a technologically advanced phospholipid delivery system to specifically pamper women by engulfing the skin in moisture, leaving it feeling silky and creamy without any greasiness. All of the Aspirations by Jennifer Greyson products have been formulated with sensitivity in mind and have not been animal tested.

PuraMed Bioscience, Inc.
OTC BB: PMBS
www.PuraMedbioscience.com
PuraMed Bioscience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading products LipiGesic M, which provides acute relief from migraine headaches; the company also has plans to launch LipiGesic PM that provides remedy for insomnia and other sleep disorders. The Company’s other products include LipiGesic H for common tension headaches.  Additional products continue to be identified at PuraMed Bioscience, Inc.

Puramed Bioscience was founded in 2006 and is based in Schofield, Wisconsin. The Company began trading under the symbol “PMBS” in May 2008. PuraMed was established to take advantage of the industry relationships fostered in the past by its management team to capture unique opportunities.

Strategic American Oil Corp.
OTC BB: SGCA
www.strategicamericanoil.com
Strategic American Oil Corporation is an exploration and production company with operations in Texas, Louisiana, and Illinois. The company draws on the talents of an internationally recognized team of geologists, engineers, and executives with extensive oil and gas exploration and production experience. The Company’s objective is to find and acquire oil and gas projects of merit and develop those projects to their full potential utilizing a low-risk, no-debt strategy.